Loading...
Chemical structure of Befotertinib

GC64017

Befotertinib

Also known as N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)indol-3-yl]pyrimidin-2-yl]amino]phenyl]prop-2-enamide

Befotertinib (D-0316) is the third-generation EGFR tyrosine kinase inhibitor· Befotertinib can be used for the research of EGFR T790M-positive non-small cell lung cancer (NSCLC)

ChemicalCAS1835667-63-4MW567.61FormulaC29H32F3N7O2
CAS number
1835667-63-4
Molecular weight
567.61
Formula
C29H32F3N7O2
Solubility
DMSO ： 62·5 mg/mL (110·11 mM; ultrasonic and warming and heat to 60°C)
InChIKey
USOCZVZOXKTJTI-UHFFFAOYSA-N
Catalogue number
GC64017
Brand
GLPBIO
Computed properties PubChem CID 130412842 · XLogP 4.8 · TPSA 87.6 Ų · H-bond donors 2
XLogP
4.8
TPSA
87.6 Ų
H-bond donors
2
H-bond acceptors
10
Rotatable bonds
11
Heavy atoms
41

SMILES CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)CC(F)(F)F)OC

Computed descriptors from PubChem (CID 130412842), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.